ZYME
Asset Logo

Zymeworks Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-12.49%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Zymeworks Inc. is a global biotechnology company. The Company is engaged in the discovery, development, and commercialization of multifunctional biotherapeutics to treat cancer and other serious diseases. Its complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop differentiated antibody-based therapeutic candidates. Its platforms include Azymetric, Drug Conjugate Platforms, EFECT, and ProTECT. Its lead product candidate, zanidatamab, is a bispecific antibody that targets two distinct domains of the human epidermal growth factor receptor 2 (HER2). Its second product candidate, zanidatamab zovodotin, combines the biparatopic antibody design of zanidatamab with its ZymeLink auristatin antibody-drug conjugate (ADC) technology, comprised of its cytotoxin (cancer cell-killing compound) and cleavable linker. Its pipeline includes four preclinical candidates: ZW191, ZW171, ZW220, and ZW251.

📈 Performance

Price History*

+2.15%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$13.28

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in ZYME

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

12 weeks

💵 Average investment amount

$328

Last time a customer invested in ZYME

54 days
ZYME investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

100%

Male

Pearlers who invest in ZYME also invest in...

Health Care Select Sector SPDR

XLV

🙌 Performance (5Yr p.a)

11.45%

📊 Share price

$147.74 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

-2.31%

📊 Share price

$21.30 USD

🙌 Performance (5Yr p.a)

204.73%

📊 Share price

$18.99 USD

📊 Share price

$7.97 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

1.51%

📊 Share price

$8.76 USD
Compare
Add to watchlist